Author

Ruixia Ma

University of GeorgiaORCID 0000-0002-5492-2575Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Adam I. Riker· 2 shared Bin YiiD· 2 shared Yaguang XiiD· 2 shared Li LiiD· 1 shared Xin ZhangiD· 1 shared Zhipin LiangiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Adam I. Riker

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyCell Death DiscoveryPeer-reviewedNov 14, 2025

Sulindac Sulfide Suppresses Oncogenic Transformation Through let-7b-Mediated Repression of K-Ras Signaling

Zhipin Liang, Ruixia Ma, Bin Yi…·Yaguang Xi

This study shows sulindac sulfide inhibits cell transformation by upregulating let-7b, which suppresses K-Ras signaling through ERK inhibition, revealing a novel regulatory axis in cancer chemoprevention.

1 citation

mousehuman

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 11, 2025

Sulindac modulates the response of triple negative breast cancer to anti-PD-L1 immunotherapy

Bin Yi, Ruixia Ma, Xin Zhang…·Yaguang Xi

This study shows that sulindac enhances anti-PD-L1 immunotherapy efficacy in TNBC by reducing exosomal PD-L1 and increasing T cell infiltration.

1 citation

mouseproteomics

𝕏 PostBluesky